Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas

International Journal of Colorectal Disease

Volumn 19, Issue 6, 2004, Pages 518-524

  Roeb, Elke ^a   Arndt, Marlies ^a   Jansen, Bettina ^a   Schumpelick, Volker ^a   Matern, Siegfried ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Colorectal cancer; Matrilysin; MMP; Quantitative PCR

Indexed keywords

COLLAGENASE 3; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; GELATINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERSTITIAL COLLAGENASE; MATRILYSIN; MESSENGER RNA; STROMELYSIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; RECTUM BIOPSY; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

AGED; CARCINOMA; CELL PROLIFERATION; COLLAGENASES; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 7444243325     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0592-6     Document Type: Article

References (34)

1. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516
2. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827-839
3. Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36:1621-1630
4. Itoh Y, Nagase H (2002) Matrix metalloproteinases in cancer. Essays Biochem 38:21-36
5. Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG (1997) Matrix metalloproteinases. Novel targets for directed cancer therapy. Drugs Aging 11:229-244
6. Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52:255-264
7. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557
8. Overall CM, McQuibban GA, Clark-Lewis I (2002) Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383:1059-1066
9. Van den Steen PE, Proost P, Grillet B, Brand DD, Kang AH, Van Damme J, Opdenakker G (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J 16:379-389
10. Roeb E, Behrmann I, Grötzinger J, Breuer B, Matern S (2000) A MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist. FASEB J 14:1671-1673
11. Roeb E, Schleinkofer K, Kernebeck T, Poetsch S, Behrmann I, Jansen B, Matern S, Grötzinger J (2002) The MMP-9 hemopexin domain is a novel gelatin binding domain and acts as an antagonist. J Biol Chem 277:50326-50332
12. Mysliwiec AG, Ornstein DL (2002) Matrix metalloproteinases in colorectal cancer. Clin Colorectal Cancer 1:208-219
13. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2:461-462
14. Zeng ZS, Huang Y, Cohen AM, Guillem JG (1996) Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 14:3133-3140
15. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45:252-258
16. Kikuchi R, Noguchi T, Takeno S, Kubo N, Uchida Y (2000) Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer 83:215-218
17. Sardinha TC, Nogueras JJ, Xiong H, Weiss EG, Wexner SD, Abramson S (2000) Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum 43:389-395
18. Roeb E, Dietrich CG, Winograd R, Arndt M, Breuer B, Faß J, Schumpelick V, Matern S (2001) Activity and cellular origin of gelatinases in colon and rectal cancer: differential activity of MMP-9. Cancer 92:2680-2691
19. Leeman MF, McKay JA, Murray GI (2002) Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 55:758-762
20. Roeb E, Purucker E, Breuer B, Nguyen HN, Heinrich PC, Rose-John S, Matern S (1997) TIMP expression in toxic and cholestatic liver injury in rats. J Hepatol 27:535-544
21. Yamashita K, Azumano I, Mai M, Okada Y (1998) Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implication for vessel invasion and metastasis. Int J Cancer 79:187-194
22. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A, Atomi Y (2001) Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84:1317-1321
23. Yamamoto H, Itoh F, Hinoda Y, Senota A, Yoshimoto M, Nakamura H, Imai K, Yachi A (1994) Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin. Biochem Biophys Res Commun 201:657-664
24. Wilson CL, Matrisian LM (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28:123-136
25. Crabbe T, Smith B, O'Connell J, Docherty A (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett 345:14-16
26. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, Okada Y (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymatic properties. J Biol Chem 270:6691-6697
27. Witty JP, McDonnell S, Newell KJ, Cannon P, Navre M, Tressler RJ, Matrisian LM (1994) Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54:4805-4812
28. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response. Am J Pathol 149:273-282
29. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80:733-743
30. Newell KJ, Witty JP, Rodgers WH, Matrisian LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10:199-206
31. Harris ED Jr, Krane SM (1974) Collagenases (second of three parts). N Engl J Med 291:605-609
32. Shiozawa J, Ito M, Nakayama T, Nakashima M, Kohno S, Sekine I (2000) Expression of matrix metalloproteinase-1 in human colorectal carcinoma. Mod Pathol 13:925-933
33. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T, Nagawa H (2000) MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 5:108-114
34. Nakopoulou L, Giannopoulou I, Gakiopoulou H, Liapis H, Tzonou A, Davaris PS (1999) Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 30:436-442